Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Re mugsy and ATE

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Jun 04, 2023 9:48am

123 Views

Post# 35479064

RE:Re mugsy and ATE

Oh - I'm losing money on ATE but I've never hid any of that.
I've also indicated that I tripled down on that one over the past 2 years.
So - let's see just how happy I'll be if ATE breaks a dollar.

If I'm right - and if ATE's new formulation is perfectly placed for acute pain (as per previous P2 data for OTENA and expectations for the final P2 coming in Q4 based on modified formulation) ... I will be very happy and so will GUD.

That all needs to play out.

You can't forget, this is drug development ChiChi. This isn't a cash-cow business.
There's nothing "easy" about it.

<< Previous

Bullboard Posts

Next >>

Canopy Growth prepares for U.S. expansion with new acquisitions